Delivery Order SPE2DB20D1102-SPE2DB24FC5VB
- Not listed
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,330.16, is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has a completion date of January 9, 2025 and is a Firm Fixed Price (FFP) contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide teriparatide 620 mcg/2.48 ml 2.48 ml. The contract has a ceiling value of $8,334.95 and a period of performance through January 6, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 620 mcg/2.48 ml vials of the drug teriparatide. The contract is a firm fixed-price delivery order with a ceiling value of $16,819.13 and a period of performance through May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company also holds a larger $999,999,999.00 Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract, valued at $1,351.47, was awarded by the Defense Logistics Agency (DLA) and has a period of performance through March 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract has a ceiling value of $1,820.84 and a period of performance through February 21, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,947.18, is for the delivery of 4,567,955,867 units of the medication teriparatide 620 mcg/2.48 ml. The contract has an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The $2,598.99 firm fixed price contract is for the supply of teriparatide 620 mcg/2.48 ml medication. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order for the product TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, with a ceiling value of $1,328.02. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a medication used to treat certain types of osteoporosis. The contract is a firm fixed-price delivery order with a ceiling value of $3,535.62 and a period of performance ending on July 16, 2025. The contract is not set aside and was openly...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB24FC5VBDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,732.66, is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about major subcontractors. The contract is for a Firm Fixed Price Delivery Order with a completion date of November 24, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/22/23 |